Abstract
Hydroxyclemastine was targeted as a versatile analogue of clemastine with H1 receptor antagonist activity. Stereoselective synthesis of (-)-hydroxyclemastine was performed in which the key step was chelation-controlled diastereoselective 1,2-addition of Grignard reagent to α-alkoxyketone.
Similar content being viewed by others
References
Ebnother, A. and Weber H. P., Synthesis and absolute configuration of clemastine and its isomers.Helv. Chim. Acta., 59, 2462–2468 (1976).
Forrat, V. J., Priesto, O., Ramon, D. J., and Yus, M.,trans-1-Sufonylamino-2-isoborneolsulfonylaminocyclohexane derivatives: Excellent chiral ligands for catalytic enantioselective addition of organozinc reagents to ketones.Chem. Eur. J., 12, 4431–4445 (2006).
Goeber, B., Mardini, M. A. A., and Franke, P., Stability and biotransformation of drugs. Part 26. Degradation products of clemastine in solutions.Pharmazie, 43, 539–41 (1988).
Jung, J. E., Ho, H., and Kim, H.-D., Bidentate chelation-controlled asymmetric synthesis of α-hydroxy esters based on the glycolate enolate alkylation.Tetrahedron Lett., 41, 1793–1796 (2000).
Nelson, W. L., Antihistamines and related antiallergic and antiulcer agents, In Williams, D. A. and Thomas, L. L. (Eds). Foye’s Principles of Medicinal Chemistry. Lippincott Williams & Wilkins, Philadelphia, pp. 794–818 (2002).
Nikiforov, T., Stanchev, S., Milenkov, B., and Dimitrov, V., A route to optically active benzyl ester of (1-methyl-2-pyrrolidinyl) acetic acid, an intermediate in the synthesis of clemastine.Synth. Commun., 20, 1977–1981 (1990).
Rhee, H. J., Beom, H. Y., and Kim, H.-D., Stereoselective synthesis of (+)-lauthisan.Tetrahedron Lett., 45, 8019–8022 (2004).
Sato, F., Kobayashi, Y., Takahashi, O., Chiba, T., Takeda, Y., and Kusakabe, M., Synthesis of the rarely obtained syn-adducts in the reaction of organocopper compounds with 2,3-O-isopropylideneglyceraldehyde. Preparation of optically active epoxy alcohols.J. Chem. Soc., Chem. Commun., 22, 1636–1638 (1985).
Takaoka, M., Optical resolution of clemastine. JP 53012857 (1978).
Vanhessche, K. P. M., and Sharpless, K. B., Ligand-dependent reversal of facial selectivity in asymmetric dihydroxylation.J. Org. Chem., 61, 7978–7979 (1996).
Vernier, J.-M., El-Abdellaoui, H., Holsenback, H., Cosford, N. D. P., Bleicher, L, barker, G., Bontempi, B., Chavez-Noriega, L., Menzaghi, F., Rao, T. S., Reid, R., Sacaan, A. I., Suto, C., Washburn, M., Lioyd, G. K., and McDonald, I. A., 4-[2-(1-Methyl-2-pyrrolidinyl) ethyl]thio]phenol hydrochloride (SIB-1553A): A novel cognitive enhancer with selectivity for neuronal nicotinic acetylcholine receptors.J. Med. Chem., 42, 1684–1686 (1999).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jung, J.W., Kim, HD. Stereoselective synthesis of (-)-hydroxyclemastine as a versatile intermediate for the h1 receptor antagonist clemastine. Arch Pharm Res 30, 1521–1525 (2007). https://doi.org/10.1007/BF02977320
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02977320